Social/economic costs and health-related quality of life in patients with scleroderma in Europe

European Journal of Health Economics

Volumn 17, Issue , 2016, Pages 109-117

  López Bastida, Julio ^a,b   Linertová, Renata ^b,c   Oliva Moreno, Juan ^a,b   Serrano Aguilar, Pedro ^b,d   Posada de la Paz, Manuel ^e   Kanavos, Panos ^f   Taruscio, Domenica ^g   Schieppati, Arrigo ^h   Iskrov, Georgi ^i,j   Péntek, Márta ^k   Delgado, Claudia ^l   von der Schulenburg, Johann Mathias ^m   Persson, Ulf ⁿ   Chevreul, Karine ^o,p,q   Fattore, Giovanni ^r  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b Unidad Docente Multiprofesional de Atención Familiar y Comunitaria Oeste   (Spain)

^c Fundación Canaria de Investigación Sanitaria FUNCANIS   (Spain)

^d Evaluation and Planning Service at Canary Islands Health Service   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^f LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

ⁱ Institute of Rare Diseases   (Bulgaria)

^j MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^k Institute of Data Analytics and Information Systems   (Hungary)

^l Federación Española de Enfermedades Raras FEDER   (Spain)

^m LEIBNIZ UNIVERSITY HANNOVER   (Germany)

ⁿ SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

^o ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^p UNIVERSITÉ PARIS DESCARTES   (France)

^q Paris Diderot University   (France)

^r BOCCONI UNIVERSITY   (Italy)

more..

Author keywords

Cost of illness; Economic burden; Health related quality of life; Localised scleroderma; Scleroderma; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BARTHEL INDEX; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; ECONOMIC EVALUATION; EUROPE; EUROQOL 5 DOMAIN; FEMALE; FRANCE; GERMANY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; HUNGARY; ITALY; LOCALIZED SCLERODERMA; MALE; MANUAL LABOR; MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; SCLERODERMA; SCORING SYSTEM; SOCIAL ASPECT; SPAIN; SWEDEN; SYSTEMIC SCLEROSIS; UNITED KINGDOM; VISUAL ANALOG SCALE; AGED; CAREGIVER; COMPARATIVE STUDY; ECONOMICS; MEDICAL LEAVE; PATIENT CARE; PSYCHOLOGY; QUESTIONNAIRE; REGISTER; SICKNESS IMPACT PROFILE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CAREGIVERS; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PATIENT CARE; QUALITY OF LIFE; REGISTRIES; SCLERODERMA, SYSTEMIC; SICK LEAVE; SICKNESS IMPACT PROFILE; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; UNITED KINGDOM; VISUAL ANALOG SCALE;

EID: 84962007710     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-016-0789-y     Document Type: Article

References (47)

1. Chifflot, H., Fautrel, B., Sordet, C., Chatelus, E., Sibilia, J.: Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin. Arthritis Rheum. 37, 223–235 (2008)
2. Czirjak, L., Kiss, C.G., Lovei, C., Suto, G., Varju, C., Fuzesi, Z.: Survey of Raynaud’s phenomenon and systemic sclerosis based on a representative study of 10,000 South-Transdanubian Hungarian inhabitants. Clin. Exp. Rheumatol. 23, 801–808 (2005)
3. Villaverde-Hueso, A., Posada-De-la-Paz, M., Martin-Arribas, M.C., Sanchez-Valle, E., Ramirez-Gonzalez, A., Biairdi, P.: Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model. Pharmacoepidemiol. Drug Saf. 17, 1100–1107 (2008)
4. Silman, A., Jannini, S., Symmons, D., Bacon, P.: An epidemiological study of scleroderma in the West Midlands. Br. J. Rheumatol. 27, 286–290 (1988)
5. Arias-Nunez, M.C., Llorca, J., Vazquez-Rodriguez, T.R., Gomez-Acebo, I., Miranda-Filloy, J.A., Martin, J.: Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Med. (Baltimore). 87, 272–280 (2008)
6. Haustein, U.F., Ziegler, V., Zschunke, E., et al.: Progressive systemic sclerosis with silicosis in the German Democratic Republic. In: Black, C.M., Myers, A.R. (eds.) Systemic sclerosis (scleroderma), pp. 138–142. Gower, New York (1985)
7. Monaco, A.L., Bruschi, M., Corte, R.L., et al.: Epidemiology of systemic sclerosis in a district of northern Italy. Clin. Exp. Rheumatol. 29(Suppl. 65), S10–S14 (2011)
8. Allcock, R.J., Forrest, I., Corris, P.A., Crook, P.R., Griffiths, I.D.: A study of the prevalence of systemic sclerosis in northeast England. Rheumatology 43, 596–602 (2004)
9. Andréasson, K., Saxne, T., Bergknut, C., Hesselstrand, R., Englund, M.: Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria. Ann. Rheum. Dis. 73(10), 1788–1792 (2014)
10. European Medicines Agency. Public summary of opinion on orphan designation. Committee for Orphan Medicinal Products. EMA/COMP/270/2003 Rev.2. 25 April 2014. http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2009/10/WC500005900.pdf (2014). Accessed 3 November 2015
11. Hunzelmann, N., Genth, E., Krieg, T., Lehmacher, W., Melchers, I., Meurer, M., et al.: The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology 47, 1185–1192 (2008)
12. Chung, L., Domsic, R.T., Lingala, B., Alkassab, F., Bolster, M., Csuka, M.E., et al.: Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Care Res. (Hoboken) 66(3), 489–495 (2014)
13. Schouffoer, A., Zirkzee, E., Henquet, S., Caljouw, M., Steup-Beekman, G., van Laar, J.: Vliet Vlieland, T.: Needs and preferences regarding health care delivery as perceived by patients with systemic sclerosis. Clin. Rheumatol. 30, 815–824 (2011)
14. López-Bastida, J., Linertová, R., Oliva-Moreno, J., Posada-de-la-Paz, M., Serrano-Aguilar, P.: Social economic costs and health-related quality of life in patients with systemic sclerosis in Spain. Arthritis Care Res. (Hoboken) 66(3), 473–480 (2014)
15. Hudson, M., Thombs, B.D., Steele, R., Panopalis, P., Newton, E., Baron, M.: Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum. 61, 1112–1120 (2009)
16. Minier, T., Pentek, M., Brodszky, V., Ecseki, A., Karpati, K., Polgar, A., et al.: Cost-of-illness of patients with systemic sclerosis in a tertiary care centre. Rheumatology (Oxford) 49, 1920–1928 (2010)
17. Bernatsky, S., Hudson, M., Panopalis, P., Clarke, A.E., Pope, J., LeClercq, S., et al, and the Canadian Scleroderma Research Group: The cost of systemic sclerosis. Arthritis Rheum. 61, 119–123 (2009)
18. Masserini, Belotti, Zeni, S., Cossutta, R., Soldi, A., Fantini, F.: Cost-of-illness in systemic sclerosis: a retrospective study of an Italian cohort of 106 patients. Reumatismo 55, 245–255 (2003)
19. Wilson, L.: Cost-of-illness of scleroderma: the case for rare diseases. Semin. Arthritis Rheum. 27, 73–84 (1997)
20. Strickland, G., Pauling, J., Cavill, C., McHugh, N.: Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools. Clin. Rheumatol. 31, 1215–1222 (2012)
21. Gualtierotti, R., Scalone, L., Ingegnoli, F., Cortesi, P., Lubatti, C., Zeni, S., et al.: Health related quality of life assessment in patients with systemic sclerosis. Reumatismo 62, 210–214 (2010)
22. Hudson, M., Thombs, B.D., Steele, R., Panopalis, P., Newton, E., Baron, M.: The Canadian Scleroderma Research Group: quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. J. Rheumatol. 36, 768–772 (2009)
23. Hudson, M., Steele, R., Taillefer, S., Baron, M.: The Canadian Scleroderma Research Group: quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II. Arthritis Rheum. 59, 270–278 (2008)
24. Andrade, T.L., Camelier, A.A., Rosa, F.W., Santos, M.P., Jezler, S., Pereira e Silva, J.L.: Applicability of the 12-Item Short-Form health survey in patients with progressive systemic sclerosis. J Bras Pneumol. 33, 414–422 (2007)
25. Khanna, D., Ahmed, M., Furst, D.E., Ginsburg, S.S., Park, G.S., Hornung, R., et al.: Health values of patients with systemic sclerosis. Arthritis Rheum. 57, 86–93 (2007)
26. Rannou, F., Poiraudeau, S., Berezne, A., Baubet, T., Le-Guern, V., Cabane, J., et al.: Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36- Item Short Form Health Survey. Arthritis Rheum. 57, 94–102 (2007)
27. Linertová, R., Serrano-Aguilar, P., Posada-de-la-Paz, M., Hens-Pérez, M., Kanavos, P., Taruscio, D., Schieppati, A., Stefanov, R., Péntek, M., Delgado, C., Graf von der Schulenburg, Persson, U., Chevreul, K., Fattore, G., Worbes-Cerezo, M., Sefton, M., López-Bastida, J., on behalf of BURQOL-RD Research Group: Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study. Health Policy 108(1), 19–26 (2012)
28. Lopez-Bastida, J., Monton-Alvarez, F., Serrano-Aguilar, P., Perestelo-Perez, L.: The social-economic costs in patients with ataxias cerebelosas in Spain. Mov. Disord. 23, 212–217 (2008)
29. Lopez-Bastida, J., Perestelo-Perez, L., Monton-Alvarez, F., Serrano-Aguilar, P., Alfonso-Sanchez, J.L.: Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain. Amyotroph Lateral Scler. 26, 1–7 (2008)
30. Brooks, R.: EuroQol: the current state of play. Health Policy 37, 53–72 (1996)
31. Lopez-Bastida, J., Oliva, J., Perestelo-Perez, L., Serrano-Aguilar, P.: The economic costs and health-related quality of life of people with HIV and AIDS in the Canary Islands. Spain. BMC Health Serv Res. 9, 55–62 (2009)
32. McDaid, D.: Estimating the costs of informal care for people with Alzheimer’s disease: methodological and practical challenges. Int. J. Geriatr. Psychiatry 16, 400–405 (2001)
33. Van den Berg, B., Brouwer, W., Koopmanschap, M.: Economic valuation of informal care: an overview of methods and applications. Eur J Health Econ. 5, 36–45 (2004)
34. Hodgson, T.A., Meiners, M.R.: Cost-of-illness methodology: a guide to assessment practices and procedures. Milbank Mem Fund Q. 60, 429–491 (1982)
35. Drummond, M.F., O’Brien, B., Stoddart, G.L., Torrance, G.W.: Methods for the economic evaluation of health care programmes, 2nd edn. Oxford University Press, Oxford (1997)
36. Dolan, P.: Modeling valuations for EuroQol health states. Med. Care 35, 1095–1108 (1997)
37. Mahoney, F.I., Barthel, D.W.: Functional evaluation: the Barthel Index. Md State Med 14, 61–65 (1965)
38. Shah, S., Vanclay, F., Cooper, B.: Improving the sensitivity of the Barthel Index for stroke rehabilitation. J. Clin. Epidemiol. 42, 703–709 (1989)
39. Ruzafa, Cid: J., Damian Moreno, J.: Valoracion de la discapacidad fisica: el Indice de Barthel. Rev Esp Salud Publica. 71, 127–137 (1997)
40. Hérbert, R., Bravo, G., Préville, M.: Reliability, validity, and reference values of the Zarit Burden Interview for assessing informal caregivers of community-dwelling older persons with dementia. Can J Aging. 494–507 (2000)
41. Szende, A., Janssen, B., Cabases, J. (eds.).: Self-Reported Population Health: An International Perspective based on EQ-5D. Springer, Netherlands (2014)
42. Oliva, J., López-Bastida, J., Montejo, A.L., Osuna, R., Duque, B.: The socioeconomic costs of mental illness in Spain. Eur. J. Health Econ. 10, 361–369 (2009)
43. Angelis, A., Tordrup, D., Kanavos, P.: Socio-Economic Burden of Rare Diseases: A Systematic Review of Cost of Illness Evidence. Health Policy 119(7), 964–979 (2015)
44. Villaverde-Hueso, A., Sanchez-Valle, E., Alvarez, E., Morant, C., Carreira, P.E., Martin-Arribas, M.C., et al.: Estimating the burden of scleroderma disease in Spain. J. Rheumatol. 34, 2236–2242 (2007)
45. Ghatnekar, O., Glenngard, A.H., Olofsson, S., Persson, U.: A literature review of instruments for measuring health-related quality of life in rare diseases: internal report of BURQOL-RD. The Swedish Institute for Health Economics. (2011)
46. Furst, D., Khanna, D., Matucci-Cerinic, M., Clements, P., Steen, V., Pope, J., et al.: Systemic sclerosis: continuing progress in developing clinical measures of response. J. Rheumatol. 34, 1194–1200 (2007)
47. Hu, T.W.: Perspectives: an international review of the national cost estimates of mental illness, 1990–2003. J. Ment. Health Policy Econ. 9, 3–13 (2006)